Search Results
Jul 01, 2026, 02:53 ET SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market
Holding AB ("SciBase") (STO: SCIB) a leader in AI-based devices for detection and prevention in dermatology, today announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking to expand the U.S. indication for Nevisense to include the assessment
More news about: SciBase
Jul 01, 2026, 02:39 ET CVLT Deadline: CVLT Investors with Losses in Excess of $100K Have Opportunity to Lead Commvault Systems, Inc. Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/cvlt-deadline-cvlt-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-commvault-systems-inc-securities-fraud-lawsuit-302815291.htmlSOURCE
More news about: THE ROSEN LAW FIRM, P. A.
Jul 01, 2026, 02:37 ET CHX Deadline: CHX Investors with Losses in Excess of $100K Have Opportunity to Lead ChampionX Corporation Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/chx-deadline-chx-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-championx-corporation-securities-fraud-lawsuit-302815288.htmlSOURCE
More news about: THE ROSEN LAW FIRM, P. A.
Jul 01, 2026, 02:19 ET Bitmine Immersion Technologies (BMNR) anuncia que as participações de ETH atingem 5,70 milhões em tokens, e o total de criptomoedas e o total de liquidez em caixa são de US$ 9,8 bilhões
prospectivas estão sujeitas a várias condições, muitas fora do controle da Bitmine, incluindo as listadas na seção "Fatores de Risco" do Formulário 10-K arquivado na SEC em 21 de novembro de 2025, assim como em quaisquer outros documentos apresentados à SEC, conforme atualizados ou alterados periodicamente.
More news about: Bitmine Immersion Technologies, Inc.
Jul 01, 2026, 02:12 ET DentScribe Introduces AI Patient Profiles and Treatment Coordinator Intelligence for DSOs and Multi-Location Dental Groups
is not shown."Dentistry is personal, but in a DSO or multi-location environment, personalization also needs to be scalable," said Dr. Vinni K. Singh, DDS, AFAAID, Founder and CEO of DentScribe. "Two patients may need the same crown, implant, aligner consult, or periodontal follow-up, but
More news about: DentScribe
Jul 01, 2026, 01:26 ET Bitmine Immersion Technologies (BMNR) annuncia che le partecipazioni in ETH raggiungono i 5,70 milioni di token, mentre le partecipazioni totali in criptovalute e contanti ammontano a 9,8 miliardi di dollari
a numerose condizioni, molte delle quali esulano dal controllo di Bitmine, comprese quelle indicate nella sezione "Fattori di rischio" del modulo 10-K di Bitmine depositato presso la SEC il 21 novembre 2025, nonché in tutti gli altri documenti depositati presso la SEC, modificati o aggiornati di volta
More news about: Bitmine Immersion Technologies, Inc.
Jun 30, 2026, 23:50 ET Der selektive PPARα-Modulator „K-808" (Pemafibrat) erhielt von der US-amerikanischen Food and Drug Administration (FDA) den Status „Breakthrough Therapy" für die Behandlung der primären biliären Cholangitis
Erkrankungen eine erhebliche Verbesserung gegenüber bestehenden Behandlungen darstellen.K-808 wurde auf der Grundlage vorläufiger Daten und Erkenntnisse aus der laufenden klinischen Phase-II-Studie (K-808-2.01) als „Breakthrough Therapy" ausgewiesen. Die Ergebnisse dieser Studie deuten auf eine signifikante
More news about: Kowa Company Ltd.
Jun 30, 2026, 22:05 ET FMC Corporation Reaches Agreement for $400 Million Minority Equity Investment from Tessenderlo Group
the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and
More news about: FMC Corporation
Jun 30, 2026, 20:00 ET 스타메드, 양성 갑상선 결절 절제술 FDA 510(k) 적응증 허가 획득
2026년 7월 1일 /PRNewswire/ -- 최소 침습 치료 기술 전문 의료기기 기업 (주)스타메드(STARMED, 대표이사 신경훈)가 미국 식품의약국(FDA)으로부터 갑상선 전용 적응증에 대해 510(k) 허가를 획득했다고 밝혔다. 해당 허가는 2026년 5월 26일자로 발효됐으며, 이로써 스타메드의 고주파 절제 시스템을 세포검사상 양성으로 확인된 적합한 갑상선 결절에 대한 초음파 유도 경피적 절제술에 사용할 수 있게 되었다. 이로써 스타메드는 갑상선 결절 절제술의
More news about: 스타메드
Jun 30, 2026, 19:00 ET 한국쓰리엠, 국제안전보건전시회 KISS 2026에서 현장 맞춤형 개인안전솔루션 공개
비치된다. 관람객들이 직접 송기식 호흡보호구를 착용하고 내부에 순환되는 시원한 바람을 피부로 느낄 수 있는 실감형 체험 공간을 운영해 고객 만족도를 극대화할 계획이다.이외에도 한국쓰리엠 부스에서는 3M™ 쿨플로우™ 밸브가 부착된 안면부 여과식 방진마스크 '8955K', 밀착도 자가점검 버튼과 음성전달판을 갖춘 직결식 호흡보호구 '시큐어클릭(Secure Click™)' 시리즈, 신제품 보안경 'GG3000' 등 다양한 제품이 전시될 예정이다. 전시 기간 동안 부스를 방문한 고객들은 3M 전문가로부터 상세한 기능과 제품별 특장점에
More news about: 3M Company
Jun 30, 2026, 19:00 ET 'Aloha all around the world:' Hawaiian Airlines unveils oneworld alliance livery aircraft featuring ʻŌlelo Hawaiʻi
livery will share Hawaiian language with guests from around the worldHawaiian celebrated the special aircraft unveiling with a donation of $10K each to ʻIolani Palace and the Polynesian Voyaging SocietyHONOLULU, June
More news about: Hawaiian Airlines
Jun 30, 2026, 18:57 ET Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/zoetis-deadline-zts-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-zoetis-inc-securities-fraud-lawsuit-302815085.htmlSOURCE
More news about: THE ROSEN LAW FIRM, P. A.
Jun 30, 2026, 18:43 ET LCID Deadline: LCID Investors with Losses in Excess of $100K Have Opportunity to Lead Lucid Group, Inc. Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/lcid-deadline-lcid-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-lucid-group-inc-securities-fraud-lawsuit-302815053.htmlSOURCE
More news about: THE ROSEN LAW FIRM, P. A.
Jun 30, 2026, 17:40 ET Powerfleet Announces New $30 Million Stock Repurchase Program
Securities and Exchange Commission (SEC), including but not limited to those described under the heading "Risk Factors" in our annual reports on Form 10-K, quarterly reports on Form 10-Q and any other filings made with the SEC from time to time, which are available via the SEC's website at
More news about: Powerfleet
Jun 30, 2026, 16:57 ET TEN Holdings, Inc. Announces Closing of $7.5 Million Offering
uncertainties related to market conditions and other factors discussed in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC"), the Registration Statements and other filings with the SEC. For these reasons, among
More news about: TEN Holdings, Inc.
Jun 30, 2026, 16:30 ET SUMMIT HOTEL PROPERTIES COMPLETES $650 MILLION CREDIT FACILITY REFINANCING
greater detail in the Company's filings with the Securities and Exchange Commission, including, without limitation, the Company's Annual Report on Form 10-K for the year ended December 31, 2025. Unless legally required, the Company disclaims any obligation to update any forward-looking statements, whether
More news about: Summit Hotel Properties, Inc.
Jun 30, 2026, 16:25 ET Perrigo Announces Appointment of Two New Independent Directors to Board
and other factors described in Perrigo's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent filings. Perrigo undertakes no obligation to update any forward-looking statements, except as required by law.Perrigo ContactsEric
More news about: Perrigo Company plc
Jun 30, 2026, 16:23 ET Facilitron University 6 to Convene National Leaders Around the Future of School Facility Stewardship
supported more than 10 million community events and manages billions of square feet of public space through its platform. Building on its leadership in K–12 education and public-sector facilities, Facilitron continues to help organizations better manage, maintain, and maximize the value of the spaces and
More news about: Facilitron
Jun 30, 2026, 16:20 ET Greenberg Traurig Strengthens Nuclear Energy Capabilities, Adds NRC Counsel Adam Gendelman
James K. Hickey;
More news about: Greenberg Traurig, LLP
Jun 30, 2026, 16:15 ET Talos Energy Announces Strategic Acquisition of Gulf of America Deepwater Oil Assets
business conditions; and the other risks and uncertainties discussed in our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other Securities and Exchange Commission filings.Should one or more of the risks or uncertainties described
More news about: Talos Energy
Jun 30, 2026, 16:15 ET Shell to sell interest in Gulf of America platform
international sanctions; (j) legislative, judicial, fiscal and regulatory developments including tariffs and regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation
More news about: Shell
Jun 30, 2026, 16:05 ET Aflac Incorporated to Release Second Quarter Results and CFO Video Update on August 6, 2026 and Host Webcast on August 7, 2026
and financial supplement, will be available, along with a financial update video from Senior Executive Vice President and Chief Financial Officer Max K. Brodén, on the company's Investor Relations website,
More news about: Aflac Incorporated
Jun 30, 2026, 16:05 ET SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
rights protecting our tests and market position; and other factors discussed under the heading "Risk Factors" contained in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to
More news about: Sera Prognostics, Inc.
Jun 30, 2026, 16:02 ET Halozyme Appoints David Ramsay as President Drug Delivery
These and other factors that may result in differences are discussed in greater detail in the Company's most recently filed Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. Halozyme undertakes no obligation to update or revise any forward-looking
More news about: Halozyme Therapeutics, Inc.
Jun 30, 2026, 15:55 ET Stoneridge Returns to Russell 2000® Index
representative of the Company's future operating profile; andthe items described in Part I, Item 1A ("Risk Factors") in the Company's most recent Form 10-K.The forward-looking statements contained herein represent our estimates only as of the date of this press release and should not be relied
More news about: Stoneridge, Inc.